Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community What are we thinking about this SCUBE3 boys

      in Product  7 upvotes 6 months ago
      SCUBE3 is a promising new molecule that can restart hair growth by reawakening dormant hair follicles. Users express skepticism about its availability timeline, with some hoping for release by 2026.

      community New Treatments, and a Huge Group Buy with Lots of Research

      in Research/Science  109 upvotes 2 years ago
      A user is organizing a group buy for various compounds aimed at reversing hair loss and gray hair, and improving brain health and fat loss. The user has developed a treatment plan based on extensive research and is inviting others to participate, with the option to choose only the compounds they need.

      community Microstamp guide?

      in Microneedling  79 upvotes 4 months ago
      Microneedling for hair loss, with concerns about cost and conflicting information on protocols. The user is unsure about purchasing and reusing microneedling stampers.

      community 5 month progress hair regrowth

      in Progress Pictures  122 upvotes 1 year ago
      The user shared their 5-month hair regrowth progress using oral finasteride daily, topical minoxidil twice daily, derma stamping weekly, castor oil weekly, and the Nioxin system kit. Replies praised the results and inquired about the timeline and side effects.

      community Is this a regrowth or I’m just trippin?

      in Is this regrowth?  7 upvotes 1 month ago
      The user has been using 3mg oral minoxidil, 1mg finasteride, microneedling, and topical 5% minoxidil for hair loss. They are unsure about the results, noticing some regrowth but feeling dissatisfied overall.

      community So Pyrilutamide has been postponed by one year. How likely is that to happen to GT20029

      in Treatment  28 upvotes 2 years ago
      The conversation discusses the delay in the release of a new hair loss treatment, Pyrilutamide, and speculates on potential safety concerns as a reason for the delay. It also mentions GT20029 as another future treatment option, with a release at least five years away, and touches on the avoidance of research chemicals due to uncertainty about their authenticity.